Brain delivery of an amyloid-β oligomer (AβO)-targeting peptide-therapeutic by a novel blood-brain barrier (BBB)-crossing domain antibody

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/j.jalz.2017.06.703
AuthorSearch for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: ; Search for: ; Search for: ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: ; Search for: 1 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleAlzheimer's & Dementia
ISSN1552-5260
Volume13
Issue7
Abstract
Publication date
PublisherElsevier
Terms of use
LanguageEnglish
Peer reviewedYes
NPARC number23002450
Export citationExport as RIS
Report a correctionReport a correction
Record identifier16c5c6bb-33b2-4d89-a2ed-f5f67cceeacd
Record created2017-11-10
Record modified2017-11-10
Date modified: